Related Experiment Video

Updated: Jul 18, 2026

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
11:01

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Published on: November 23, 2016

Synthesis and evaluation of N-acetyl-L-tyrosine based compounds as PPARalpha selective activators

Rakesh Kumar1, Uma Ramachandran, Suryaprakash Raichur

  • 1Department of Pharmaceutical Technology, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160 062, India.

European Journal of Medicinal Chemistry
|December 26, 2006
PubMed

Insights

New N-acetyl-L-tyrosine derivatives show promise in treating type 2 diabetes by targeting lipid accumulation. Compounds 4d and 4f effectively activate PPARalpha, offering a potential therapeutic strategy for obesity-related metabolic dysfunction.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Obesity is linked to type 2 diabetes via lipid accumulation in non-adipose tissues.
  • Peroxisome proliferator-activated receptors (PPARs) are key regulators of lipid metabolism and insulin sensitivity.

Purpose of the Study:

  • To synthesize and evaluate novel N-acetyl-L-tyrosine derivatives for their ability to modulate PPAR transactivation.
  • To identify compounds with selective activity towards PPARalpha over PPARgamma for potential therapeutic applications in metabolic diseases.

Main Methods:

  • Synthesis of a series of N-acetyl-L-tyrosine derivatives.
  • In vitro evaluation of compounds for PPARalpha and PPARgamma transactivation activity.
  • Molecular docking analysis to investigate ligand-receptor interactions within the PPARalpha active site.

Main Results:

  • Compounds 4d and 4f demonstrated significant PPARalpha transactivation.
  • These compounds exhibited superior PPARalpha activity compared to PPARgamma activation.
  • Molecular docking provided insights into the binding modes and key interactions of 4d and 4f with PPARalpha.

Conclusions:

  • N-acetyl-L-tyrosine derivatives 4d and 4f are potent activators of PPARalpha.
  • These findings suggest a potential therapeutic avenue for managing lipid accumulation and type 2 diabetes in obese individuals.
  • Further studies are warranted to explore the in vivo efficacy and safety of these compounds.

More Related Videos

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...